173 related articles for article (PubMed ID: 19514716)
1. In vivo stable tumor-specific painting in various colors using dehalogenase-based protein-tag fluorescent ligands.
Kosaka N; Ogawa M; Choyke PL; Karassina N; Corona C; McDougall M; Lynch DT; Hoyt CC; Levenson RM; Los GV; Kobayashi H
Bioconjug Chem; 2009 Jul; 20(7):1367-74. PubMed ID: 19514716
[TBL] [Abstract][Full Text] [Related]
2. The use of fluorescent proteins for developing cancer-specific target imaging probes.
McCann TE; Kosaka N; Choyke PL; Kobayashi H
Methods Mol Biol; 2012; 872():191-204. PubMed ID: 22700412
[TBL] [Abstract][Full Text] [Related]
3. Galactosyl human serum albumin-NMP1 conjugate: a near infrared (NIR)-activatable fluorescence imaging agent to detect peritoneal ovarian cancer metastases.
Alexander VM; Sano K; Yu Z; Nakajima T; Choyke PL; Ptaszek M; Kobayashi H
Bioconjug Chem; 2012 Aug; 23(8):1671-9. PubMed ID: 22799539
[TBL] [Abstract][Full Text] [Related]
4. A self-quenched galactosamine-serum albumin-rhodamineX conjugate: a "smart" fluorescent molecular imaging probe synthesized with clinically applicable material for detecting peritoneal ovarian cancer metastases.
Hama Y; Urano Y; Koyama Y; Gunn AJ; Choyke PL; Kobayashi H
Clin Cancer Res; 2007 Nov; 13(21):6335-43. PubMed ID: 17975145
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the emission efficiency of four common green fluorescence dyes after internalization into cancer cells.
Hama Y; Urano Y; Koyama Y; Bernardo M; Choyke PL; Kobayashi H
Bioconjug Chem; 2006; 17(6):1426-31. PubMed ID: 17105220
[TBL] [Abstract][Full Text] [Related]
6. Near infrared fluorescence-guided real-time endoscopic detection of peritoneal ovarian cancer nodules using intravenously injected indocyanine green.
Kosaka N; Mitsunaga M; Longmire MR; Choyke PL; Kobayashi H
Int J Cancer; 2011 Oct; 129(7):1671-7. PubMed ID: 21469142
[TBL] [Abstract][Full Text] [Related]
7. Fluorophore-quencher based activatable targeted optical probes for detecting in vivo cancer metastases.
Ogawa M; Kosaka N; Longmire MR; Urano Y; Choyke PL; Kobayashi H
Mol Pharm; 2009; 6(2):386-95. PubMed ID: 19718793
[TBL] [Abstract][Full Text] [Related]
8. Fluorogenic Protein Probes with Red and Near-Infrared Emission for Genetically Targeted Imaging*.
Bachollet SPJT; Addi C; Pietrancosta N; Mallet JM; Dumat B
Chemistry; 2020 Nov; 26(63):14467-14473. PubMed ID: 32691883
[TBL] [Abstract][Full Text] [Related]
9. In vivo breast cancer characterization imaging using two monoclonal antibodies activatably labeled with near infrared fluorophores.
Sano K; Mitsunaga M; Nakajima T; Choyke PL; Kobayashi H
Breast Cancer Res; 2012; 14(2):R61. PubMed ID: 22510481
[TBL] [Abstract][Full Text] [Related]
10. Determination of optimal rhodamine fluorophore for in vivo optical imaging.
Longmire MR; Ogawa M; Hama Y; Kosaka N; Regino CA; Choyke PL; Kobayashi H
Bioconjug Chem; 2008 Aug; 19(8):1735-42. PubMed ID: 18610943
[TBL] [Abstract][Full Text] [Related]
11. Activatable organic near-infrared fluorescent probes based on a bacteriochlorin platform: synthesis and multicolor in vivo imaging with a single excitation.
Harada T; Sano K; Sato K; Watanabe R; Yu Z; Hanaoka H; Nakajima T; Choyke PL; Ptaszek M; Kobayashi H
Bioconjug Chem; 2014 Feb; 25(2):362-9. PubMed ID: 24450401
[TBL] [Abstract][Full Text] [Related]
12. In vivo imaging of intraperitoneally disseminated tumors in model mice by using activatable fluorescent small-molecular probes for activity of cathepsins.
Fujii T; Kamiya M; Urano Y
Bioconjug Chem; 2014 Oct; 25(10):1838-46. PubMed ID: 25196809
[TBL] [Abstract][Full Text] [Related]
13. Targeted optical fluorescence imaging of human ovarian adenocarcinoma using a galactosyl serum albumin-conjugated fluorophore.
Gunn AJ; Hama Y; Koyama Y; Kohn EC; Choyke PL; Kobayashi H
Cancer Sci; 2007 Nov; 98(11):1727-33. PubMed ID: 17784874
[TBL] [Abstract][Full Text] [Related]
14. Dynamic fluorescent imaging with the activatable probe, γ-glutamyl hydroxymethyl rhodamine green in the detection of peritoneal cancer metastases: Overcoming the problem of dilution when using a sprayable optical probe.
Nakamura Y; Harada T; Nagaya T; Sato K; Okuyama S; Choyke PL; Kobayashi H
Oncotarget; 2016 Aug; 7(32):51124-51137. PubMed ID: 27286461
[TBL] [Abstract][Full Text] [Related]
15. Fluoromodule-based reporter/probes designed for in vivo fluorescence imaging.
Zhang M; Chakraborty SK; Sampath P; Rojas JJ; Hou W; Saurabh S; Thorne SH; Bruchez MP; Waggoner AS
J Clin Invest; 2015 Oct; 125(10):3915-27. PubMed ID: 26348895
[TBL] [Abstract][Full Text] [Related]
16. Shortwave infrared emitting multicolored nanoprobes for biomarker-specific cancer imaging in vivo.
Kantamneni H; Barkund S; Donzanti M; Martin D; Zhao X; He S; Riman RE; Tan MC; Pierce MC; Roth CM; Ganapathy V; Moghe PV
BMC Cancer; 2020 Nov; 20(1):1082. PubMed ID: 33172421
[TBL] [Abstract][Full Text] [Related]
17. In vivo spectral fluorescence imaging of submillimeter peritoneal cancer implants using a lectin-targeted optical agent.
Hama Y; Urano Y; Koyama Y; Kamiya M; Bernardo M; Paik RS; Krishna MC; Choyke PL; Kobayashi H
Neoplasia; 2006 Jul; 8(7):607-12. PubMed ID: 16867223
[TBL] [Abstract][Full Text] [Related]
18. Multicolor in vivo targeted imaging to guide real-time surgery of HER2-positive micrometastases in a two-tumor coincident model of ovarian cancer.
Longmire M; Kosaka N; Ogawa M; Choyke PL; Kobayashi H
Cancer Sci; 2009 Jun; 100(6):1099-104. PubMed ID: 19302283
[TBL] [Abstract][Full Text] [Related]
19. In Vivo Fluorescent Labeling of Tumor Cells with the HaloTag® Technology.
Tseng JC; Benink HA; McDougall MG; Chico-Calero I; Kung AL
Curr Chem Genomics; 2012; 6():48-54. PubMed ID: 23115613
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
